Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Front Range Biosciences Raises $10M In Series A Financing
Venture Capital

Front Range Biosciences Raises $10M In Series A Financing

by posted 1year ago 73 views
BOULDER, Colo., October 4, 2018-- Front Range Biosciences®, a leading agricultural biotech company specializing in tissue culture propagation of high value crops, today announced that it has completed a $10 million Series A round of financing with participation from Phyto Partners, WelCan Capital, Salveo Capital, Cornerstone Opportunity Partners, Sand Hill Angels, Harvard Business School Alumni Angels of New York, New York Angels, Altitude Investment Management, and other new and returning investors. This marks the largest fundraising by a U.S. cannabis biotech company to date.